Haematologica, Vol 92, Issue 12, 1709-1710 doi:10.3324/haematol.11253
Copyright © 2007 by Ferrata Storti Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Montalembert, M.
Right arrow Articles by Bonnet, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Montalembert, M.
Right arrow Articles by Bonnet, D.

Red Cell Disorders

Endothelial-dependent vasodilation is impaired in children with sickle cell disease

Mariane de Montalembert*,, Yacine Aggoun°, Assa Niakate*, Isabelle Szezepanski°, Damien Bonnet°

* Service de Pédiatrie Générale;
° Service de Cardiologie Pédiatrique, Hôpital Necker, Paris, France

Correspondence: Mariane de Montalembert, Service de Pediatrie Generale, Hopital Necker, 149 rue de Sevres, 75015 Paris, France. E-mail: mariane.demontal{at}nck.aphp.fr


arrow
ABSTRACT
TOP
 ABSTRACT
References
 
Impairment of endothelial-dependent vasodilation has been demonstrated in adults with sickle cell anemia (SCA). We enrolled 21 SCA children, mean age 10.4±3.3 yrs, and 23 Afro-Caribbean controls. We examined flow-mediated (FMD) and nitroglycerine-mediated (GTNMD) dilation of the brachial artery, using echotracking techniques, and measured intima-media thickness (IMT) and mechanical properties of the common carotid artery. FMD was significantly decreased in SCA children vs controls (5.6±0.2 vs 8.0±0.2%, p=0.008), while IMT, stiffness of the common carotid artery, and GTNMD were comparable. In conclusion, endothelial dysfunction is present as early as childhood in SCA patients.

Sickle cell anemia (SCA) is characterized by hemoglobin S polymerization, chronic hemolytic anemia, adherence of young red cells to the venular endothelium, chronic inflammation, and ischemia-reperfusion injury leading to endothelium damage and recurrent painful vasocclusion. Availability of the major endothelial vasodilator, nitric oxide (NO), may be reduced by the scavenging of cell-free hemoglobin and destruction by arginase released during hemolysis.1 Sickle transgenic mice had a decreased arteriolar dilation in response to NO-mediated vasodilators.2,3

A reduction of the flow-mediated vasodilation, secondary to NO release from the endothelium following an increase in wall shear stress, has been reported in SCA adult patients.4–6 No study of vascular tone had been performed in SCA children, and it is not known whether impairment of vasodilation could be observed early in childhood. We therefore studied arterial stiffness and endothelial- and non-endothelial-mediated vasodilation in SCA children, using non-invasive ultra-sonographic techniques.

We enrolled 21 children with SCA (18 homozygous SS, 3 S-β0 thalassemics) who were asymptomatic at the time of enrolment (12 males, 9 females, mean age 10.4±3.3 years, mean hemoglobin level 7.6±1.0 g/dL). None had undergone blood transfusion in the previous 3 months, or were treated with hydroxyurea. These SCA children were compared to a control group of 23 Afro-Caribbean AA and AS controls, matched for age and gender, selected from among siblings of our patients. Our institutional review board approved the protocol and written informed consent was obtained from all parents.

Blood pressure and vascular function parameters were measured after the child had been recumbent for at least 10 minutes. Change in right brachial artery diameter in response to reactive hyperemia (flow increase inducing endothelium-dependent vasodilation) and change induced by glyceryltrinitrate (GTN), an endothelium-independent vasodilator, were measured in SCA and in controls using echotracking techniques. The maximum flow-mediated dilation (FMD) and GTN mediated dilation (GTNMD) were calculated as the percent change in diameter compared with baseline resting diameter. We inflated a blood-pressure cuff to 300 mmHg for 4 min., the artery was scanned for 30 sec. before and 90 sec. after the cuff deflation. Ten minutes later, a resting scan was recorded. GTNMD was determined after the administration of glyceyltrinitrate sublingually. Additionally, intima-media thickness (IMT) and mechanical properties of the common carotid artery were measured using previously described methods.7

All statistical analyses were performed using StatViewTM SE software. Blood pressure of SCA and control children was comparable. This contrasts with previous findings in SCA adults, who had significantly lower blood pressure.8 There was no difference in SCA children (0.42±0.06 mm) and controls (0.42±0.03 mm). Systolic and diastolic diameters of the common carotid artery were significantly higher in SCA children than in controls (6.8±0.8 vs 5.7±0.4, p<0.001 and 5.7±0.7 vs 5.0±0.4 mm, respectively, p<0.005). However, there was no difference in the stiffness of the common carotid artery between SCA children and control. This leads us to hypothesize that the increase of the carotid artery diameters, without modification of the distensibility, was related to the higher cardiac output secondary to anemia.9 Finally, FMD was significantly decreased in SCA children compared with controls (5.6±0.2 vs 8.0±0.2%, p=0.008) while GTNMD was comparable in SCA patients and controls (20±8 vs 21±8%). There was no correlation between FMD and either age or hemoglobin level. Reduced FMD and preserved nitrate-mediated vasodilation had also been observed in a group of 47 sickle-thalassemia adult patients.6 However, these adult patients had, contrary to our children, an increased aortic stiffness, which would suggest that the endothelial dysfunction we observed in children could be the first step of a process which progressively modifies the mechanical properties of the arterial wall in adults. This study was designed before the evidence of the correlation between lactate deshydrogenase (LDH) elevation, NO resistance and endothelial dysfunction10 was reported, so LDH levels were not assessed in our patients.

Interestingly, our observations were made on large vessels, such as common carotid and brachial arteries. This underlines the fact that SCA is not only a microvascular disease but also involves large vessels. This is seen by the occurrence of occlusion of the supraclinoid internal carotid or middle and anterior cerebral arteries, with a risk of stroke of 11% by the age of 20 and evidence of hyperplasia of intima of the supraclinoid internal carotid from autopsy findings.11

None of our patients had had a stroke. Transcranial Doppler was performed in 15 out of the 21 children enrolled in our study. Fourteen of them were normal, and one was pathological. This was observed 21 months after the cardiac examination of a 13-year-old child whose FMD was within the values observed in SCA patients.

To summarize, we concluded that the impaired flow-mediated dilation of the brachial artery, probably related to endothelial dysfunction, is observed in children with SCA who lack evidence of arterial stiffness or intimal thickening. This suggests that therapies intended to increase NO, such as arginine administration12 should be considered in children with SCA.


arrow
Footnotes
 
Funding: this study was supported by the Institut National de la Santé et de la Recherche Médicale (RBM-02 12).


arrow
References
TOP
 ABSTRACT
 References
 
  1. Reiter CD, Gladwin MT. An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy. Curr Opin Hematol 2003;10:99-107.[CrossRef][Web of Science][Medline]
  2. Kaul DK, Liu XD, Fabry ME, Nagel RL. Impaired nitric-oxide mediated vasodilation in transgenic sickle mouse. Am J Physiol Heart Circ Physiol 2000;278:H799-H1806.
  3. Nath KA, Shah V, Haggard JJ, Croatt AJ, Smith LA, Hebbel RP, et al. Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease. Am J Physiol Regul Integr Comp Physiol 2000;279:R1949-R1955.[Abstract/Free Full Text]
  4. Eberhardt E, McMahon L, Duffy SJ, Steinberg MH, Perrine SP, Loscalzo J, et al. Sickle cell anemia is associated with reduced nitric oxide bioactivity in peripheral conduit and resistance vessels. Am J Hematol 2003;74:104-11.[CrossRef][Web of Science][Medline]
  5. Belhassen L, Pelle G, Sediame S, Bachir D, Carville C, Bucherer C, et al. Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation. Blood 2001;97:1584-9.[Abstract/Free Full Text]
  6. Aessopos A, Farmakis D, Tsironi M, Diamanti-Kandarakis E, Matzourani M, Fragodimiri C, et al. Endothelial function and arterial stiffness in sickle-thalassemia patients. Atherosclerosis 2007;427-32.
  7. Tounian P, Aggoun Y, Dubern B, Varille V, Guy-Grand B, Sidi D, et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet 2001;358:1400-4.[CrossRef][Web of Science][Medline]
  8. Pegelow CH, Colangelo L, Steinberg M, Wright EC, Smith J, Phillips G, et al. Natural history of blood pressure in sickle cell disease: risks for stroke and death are associated with relative hypertension in sickle cell anemia. Am J Med 1997;102:171-7.[CrossRef][Web of Science][Medline]
  9. Varat MA, Adolph RJ, Fowler NO. Cardiovascular effects of anemia. Am Heart J 1972;83:415-26.[CrossRef][Web of Science][Medline]
  10. Kato GJ, McGowan V, Machado RF, Little JA, Taylor J 6th, Morris CR, et al. Lactate deshydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 2006;107:2279-85.[Abstract/Free Full Text]
  11. Switzer JA, Hess DC, Nichols FT, Adams RJ. Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol 2006;5:501-12.[CrossRef][Web of Science][Medline]
  12. Morris CR, Kuypers FA, Larkin S, Sweeters N, Simon J, Vichinsky EP, et al. Arginine therapy: a novel strategy to induce nitric oxide production in sickle cell disease. Br J Haematol 2000;111:498-500.[CrossRef][Web of Science][Medline]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Montalembert, M.
Right arrow Articles by Bonnet, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Montalembert, M.
Right arrow Articles by Bonnet, D.